Scilex Holding CO Schedule 13D activist filings

SCLX Stock Acquisition JV LLC has filed an amendment to its Schedule 13D, reporting changes in its beneficial ownership of Scilex Holding Company common stock and Series A Preferred Stock.

Scilex Holding Company reports a dividend distribution of Semnur Pharmaceuticals common stock to its shareholders.

Scilex Holding Company has increased its beneficial ownership in Datavault AI Inc. to 37.27% through recent stock purchases.

Scilex Holding Company has increased its beneficial ownership in Datavault AI Inc. to 40.05% through recent stock acquisitions.

Scilex Holding Company updated its Schedule 13D, disclosing a significant increase in its beneficial ownership of Datavault AI Inc. and the pledging of 85.8 million shares as collateral for a $100 million non-recourse loan.

Scilex Holding Company has significantly increased its beneficial ownership in Datavault AI Inc. to 47.99% after purchasing and exercising a Pre-Funded Warrant.

Scilex Holding Company filed an amended Schedule 13D for Semnur Pharmaceuticals, Inc. to correct a previous filing error and detail its significant beneficial ownership and control following a recent business combination.

Scilex Holding Company has acquired an initial 8.03% stake in Datavault AI Inc. and plans a significant further investment via a pre-funded warrant, contingent on stockholder approval.

Scilex Holding Company and its subsidiaries report beneficial ownership of 79.89% of Semnur Pharmaceuticals, Inc. common stock following a business combination and strategic share transactions.

SCLX Stock Acquisition JV LLC has amended its Schedule 13D, detailing the transfer of shares and an extension of a debt maturity date.

Scilex Holding Company and its guarantor, SCLX Stock Acquisition JV LLC, have successfully deferred a significant Tranche B Notes amortization payment until October 2026, in exchange for a cash payment and the transfer of 5 million common shares by the guarantor to noteholders.